Two Sigma Investments, LP Abvc Biopharma, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.5 - $0.92 $1,400 - $2,576
-2,800 Reduced 11.24%
22,101 $11,000
Q1 2023

May 15, 2023
BUY
$0.57 - $1.07 $14,193 - $26,644
24,901 New
24,901 $15,000

About ABVC BIOPHARMA, INC.

ABVC Quotes by TradingView
  • Ticker ABVC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,632,300
  • Market Cap $22.8M
  • Description
  • ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...
More about ABVC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email